Back
Fulcrum Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
32
FULC
Fulcrum Therapeutics
Last Price:
2.99
Seasonality Move:
63.73%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Sell |
| 20-day SMA: | 3.29 | Sell |
| 50-day SMA: | 3.52 | Sell |
| 200-day SMA: | 7.22 | Sell |
| 8-day EMA: | 3.17 | Sell |
| 20-day EMA: | 3.33 | Sell |
| 50-day EMA: | 4.09 | Sell |
| 200-day EMA: | 6.03 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 32.8 | Sell |
| Chaikin Money Flow: | -260754 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.12 - 3.52) | Sell |
| Bollinger Bands (100): | (3.37 - 8.57) | Sell |
Fulcrum Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 2.99 while FULC 8-day simple moving average is 3.28, which is a Sell signal.
- The stock price of FULC is 2.99 while Fulcrum Therapeutics 20-day SMA is 3.29, which makes it a Sell.
- Fulcrum Therapeutics 50-day simple moving average is 3.52 while FULC share price is 2.99, making it a Sell technically.
- FULC stock price is 2.99 and Fulcrum Therapeutics 200-day simple moving average is 7.22, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
32
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a Sell
The current Fulcrum Therapeutics [FULC] share price is $2.99. The Score for FULC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
161.28M
Price in USD:
2.99
Share Volume:
782.26K
Fulcrum Therapeutics 52-Week Range
52-Week High:
13.70
52-Week Low:
2.87
Sell
32
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?
The Fulcrum Therapeutics stock price is 2.99 USD today. -
Will FULC stock go up or go down?
Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Fulcrum Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 2.99 while FULC 8-day exponential moving average is 3.17, which is a Sell signal.
- The stock price of FULC is 2.99 while Fulcrum Therapeutics 20-day EMA is 3.33, which makes it a Sell.
- Fulcrum Therapeutics 50-day exponential moving average is 4.09 while FULC share price is 2.99, making it a Sell technically.
- FULC stock price is 2.99 and Fulcrum Therapeutics 200-day simple moving average is 6.03, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
- FULC Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Fulcrum Therapeutics is a Sell
- Fulcrum Therapeutics Relative Strength Index (RSI) is 32.8, which suggest Fulcrum Therapeutics is oversold
- The Bollinger Bands (25) for Fulcrum Therapeutics is (3.12 - 3.52), which suggest Fulcrum Therapeutics is a Sell
- The Bollinger Bands (100) for Fulcrum Therapeutics is (3.37 - 8.57), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.